Poseida Therapeutics, Inc., Expands into JLABS to Foster Research Collaboration with Janssen for Development of Allogeneic CAR-T Therapies

San Diego, CA, May 28th, 2015 — Poseida Therapeutics, Inc. (“Poseida”), a privately-held human therapeutics spinout of Transposagen Biopharmaceuticals, Inc. (“Transposagen”), has announced it has begun drug development operations at its new location at JLABS in San Diego, California.

The drug development and license agreement between Transposagen and Janssen, which was announced in November of 2014, has been transferred to […]

By |May 28th, 2015|News|0 Comments